Gene: UPRT
Official Full Name: uracil phosphoribosyltransferase homologprovided by HGNC
Gene Summary: This gene encodes uracil phosphoribosyltransferase, which catalyzes the conversion of uracil and 5-phosphoribosyl-1-R-diphosphate to uridine monophosphate (UMP). This reaction is an important part of nucleotide metabolism, specifically the pyrimidine salvage pathway. The enzyme localizes to the nucleus and cytoplasm. The protein is a potential target for rational design of drugs to treat parasitic infections and cancer. [provided by RefSeq, Nov 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25867 | UPRT Knockout cell line (HeLa) | Human | UPRT | 1:3~1:6 | Negative | Online Inquiry |
KO25868 | UPRT Knockout cell line (HCT 116) | Human | UPRT | 1:2~1:4 | Negative | Online Inquiry |
KO25869 | UPRT Knockout cell line (HEK293) | Human | UPRT | 1:3~1:6 | Negative | Online Inquiry |
KO25870 | UPRT Knockout cell line (A549) | Human | UPRT | 1:3~1:4 | Negative | Online Inquiry |
UPRT Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of Uracil Phosphoribosyltransferase (UPRT) functionality and its implications in various biological processes. By employing CRISPR-Cas9 technology, these cell lines have been meticulously developed to delete the UPRT gene, a crucial enzyme in the pyrimidine salvage pathway, which is responsible for the conversion of uracil to uridine monophosphate (UMP). This knockout mechanism allows researchers to dissect the role of UPRT in nucleotide metabolism, RNA synthesis, and cellular response to drug treatments.
The primary function of UPRT is to synthesize nucleotide precursors necessary for the generation of RNA and DNA. This makes the UPRT Gene Knockout Cell Lines invaluable tools for investigating the effects of uracil deprivation and the subsequent impacts on cellular stress responses and proliferation rates. In clinical settings, these cell lines can be utilized in preclinical drug development, especially in assessing the efficacy of UPRT-targeting therapies and evaluating resistance mechanisms in cancer cells relying on alternative nucleotide synthesis pathways.
What sets UPRT Gene Knockout Cell Lines apart from traditional cell lines is their specificity and precision in targeting the UPRT gene, leading to reproducible and reliable results. Unlike other knockout models, these lines provide a clearer understanding of UPRT’s role in cellular metabolism without off-target effects that can skew experimental outcomes. Researchers, clinicians, and pharmaceutical developers will find these cell lines to be essential for advancing our understanding of metabolic pathways and for translating findings into therapeutic strategies.
With extensive expertise in genetic engineering and a commitment to delivering high-quality biological products, our company is devoted to furthering research and innovation in the life sciences. The UPRT Gene Knockout Cell Lines exemplify our dedication to providing tools that empower researchers in their pursuit of groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.